Healthy Skepticism Library item: 4052

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Double standard labelling of pharmaceuticals sold in Thailand
Drug Study Group 1990; 3

Abstract:

Twenty-six pharmaceutical product leaflets from 13 United States companies were collected during October 1989 and then analyzed by comparing these leaflets to the information in the 1989 version of the Physicians’ Desk Reference. Double standards were found in all 26 leaflets. There were double standards in “indications” 77% of the time, followed by warnings/precautions, administration and dosage and contraindications 54, 50 and 46% of the time, respectively. Double standards present in three ways: overlabeling in areas such as indications, underlabeling in areas such as warnings/precautions, contraindications, adverse reactions and side effects, and differences in areas such as administration and dosage and chemical structure.

Keywords:
*analytic survey/Thailand/United States/developing countries/labeling/safety & risk information/quality of information/EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES/EVALUATION OF PROMOTION: LABELLING AND PACKAGE INSERTS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES